mtl-cebpa
Nucleic acidexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02716012)
Timeline
Indications
Mechanism of action
- CCAAT/enhancer-binding protein zetaSupplementation
CEBPZ supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- mtl-cebpa
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04710641 | Phase 2 | Dec 1, 2021 | Mina Alpha Limited |
| NCT05097911 | Phase 1 | Aug 2, 2021 | National University of Singapore |
| NCT04105335 | Phase 1 | Nov 1, 2019 | Mina Alpha Limited |
| NCT02716012 | Phase 1 | Mar 1, 2016 | Mina Alpha Limited, University of London |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mina Alpha Limited | For profit | 3 | 3 | 2 | 2016 |
| National University of Singapore | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1